» Articles » PMID: 32392830

Resolution of Fetal Hydrops Dependent on Sustained Fetal Supraventricular Tachycardia After Digoxin Therapy

Overview
Publisher MDPI
Specialty General Medicine
Date 2020 May 13
PMID 32392830
Authors
Affiliations
Soon will be listed here.
Abstract

We present a special case of fetal supraventricular tachycardia detected at 34 weeks gestation. Fetal hydrops was noted on ultrasound upon admission. Normal fetal heart rate was maintained for three weeks by maternal administration of digoxin. A live infant was delivered via caesarian section at 37 weeks gestation. This clinical case demonstrated that pharmacological treatment can be effective and helps to prolong pregnancy safely.

References
1.
Sridharan S, Sullivan I, Tomek V, Wolfenden J, Skovranek J, Yates R . Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols. Heart Rhythm. 2016; 13(9):1913-9. DOI: 10.1016/j.hrthm.2016.03.023. View

2.
Chung M, Schweikert R, Wilkoff B, Niebauer M, Pinski S, Trohman R . Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications. J Am Coll Cardiol. 1998; 32(1):169-76. DOI: 10.1016/s0735-1097(98)00189-2. View

3.
Saad A, Monsivais L, Pacheco L . Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?. AJP Rep. 2016; 6(3):e272-6. PMC: 4980130. DOI: 10.1055/s-0036-1586241. View

4.
Maeno Y, Hirose A, Kanbe T, Hori D . Fetal arrhythmia: prenatal diagnosis and perinatal management. J Obstet Gynaecol Res. 2009; 35(4):623-9. DOI: 10.1111/j.1447-0756.2009.01080.x. View

5.
Silver L, Platt L, Santulli Jr T, Carlson D . Resolution of hydrops fetalis despite persistent fetal tachycardia. J Ultrasound Med. 2001; 20(10):1141-5. DOI: 10.7863/jum.2001.20.10.1141. View